Bioventix PLC
LSE:BVXP
Bioventix PLC
Net Income (Common)
Bioventix PLC
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Bioventix PLC
LSE:BVXP
|
Net Income (Common)
£8.7m
|
CAGR 3-Years
9%
|
CAGR 5-Years
9%
|
CAGR 10-Years
18%
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Net Income (Common)
-$151.1m
|
CAGR 3-Years
-142%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Net Income (Common)
-$208.4m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Net Income (Common)
-$180.7m
|
CAGR 3-Years
-52%
|
CAGR 5-Years
-53%
|
CAGR 10-Years
N/A
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Net Income (Common)
-£55.3m
|
CAGR 3-Years
9%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
Genus PLC
LSE:GNS
|
Net Income (Common)
£33.4m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
3%
|
See Also
What is Bioventix PLC's Net Income (Common)?
Net Income (Common)
8.7m
GBP
Based on the financial report for Dec 31, 2023, Bioventix PLC's Net Income (Common) amounts to 8.7m GBP.
What is Bioventix PLC's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
18%
Over the last year, the Net Income (Common) growth was 3%. The average annual Net Income (Common) growth rates for Bioventix PLC have been 9% over the past three years , 9% over the past five years , and 18% over the past ten years .